Fig. 1From: Clinical outcome of stereotactic body radiotherapy for primary and oligometastatic lung tumors: a single institutional study with almost uniform dose with different five treatment schedulesFailure patterns of the 40 disease progressions that were encountered during follow-up of the 100 patients included in this studyBack to article page